BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 34605891)

  • 1. Fish intake, n-3 fatty acid body status, and risk of cognitive decline: a systematic review and a dose-response meta-analysis of observational and experimental studies.
    Kosti RI; Kasdagli MI; Kyrozis A; Orsini N; Lagiou P; Taiganidou F; Naska A
    Nutr Rev; 2022 May; 80(6):1445-1458. PubMed ID: 34605891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 Fatty Acids and Maternal and Child Health: An Updated Systematic Review.
    Newberry SJ; Chung M; Booth M; Maglione MA; Tang AM; O'Hanlon CE; Wang DD; Okunogbe A; Huang C; Motala A; Trimmer M; Dudley W; Shanman R; Coker TR; Shekelle PG
    Evid Rep Technol Assess (Full Rep); 2016 Oct; (224):1-826. PubMed ID: 30307735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Relationship of Omega-3 Fatty Acids with Dementia and Cognitive Decline: Evidence from Prospective Cohort Studies of Supplementation, Dietary Intake, and Blood Markers.
    Wei BZ; Li L; Dong CW; Tan CC; ; Xu W
    Am J Clin Nutr; 2023 Jun; 117(6):1096-1109. PubMed ID: 37028557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: a dose-response meta-analysis of 21 cohort studies.
    Zhang Y; Chen J; Qiu J; Li Y; Wang J; Jiao J
    Am J Clin Nutr; 2016 Feb; 103(2):330-40. PubMed ID: 26718417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 fatty acids and cognitive function.
    Welty FK
    Curr Opin Lipidol; 2023 Feb; 34(1):12-21. PubMed ID: 36637075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ω-3 fatty acids in the prevention of cognitive decline in humans.
    Cederholm T; Salem N; Palmblad J
    Adv Nutr; 2013 Nov; 4(6):672-6. PubMed ID: 24228198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No Effect of Omega-3 Fatty Acid Supplementation on Cognition and Mood in Individuals with Cognitive Impairment and Probable Alzheimer's Disease: A Randomised Controlled Trial.
    Phillips MA; Childs CE; Calder PC; Rogers PJ
    Int J Mol Sci; 2015 Oct; 16(10):24600-13. PubMed ID: 26501267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fish and Omega-3 Fatty Acids: Sex and Racial Differences in Cardiovascular Outcomes and Cognitive Function.
    Welty FK; Daher R; Garelnabi M
    Arterioscler Thromb Vasc Biol; 2024 Jan; 44(1):89-107. PubMed ID: 37916414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk.
    Devore EE; Grodstein F; van Rooij FJ; Hofman A; Rosner B; Stampfer MJ; Witteman JC; Breteler MM
    Am J Clin Nutr; 2009 Jul; 90(1):170-6. PubMed ID: 19474131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of omega-3 fatty acid DHA and EPA supplementation in pregnant or breast-feeding women on cognitive performance of children: systematic review and meta-analysis.
    Lehner A; Staub K; Aldakak L; Eppenberger P; Rühli F; Martin RD; Bender N
    Nutr Rev; 2021 Apr; 79(5):585-598. PubMed ID: 32918470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-3 fatty acids and blood-based biomarkers in Alzheimer's disease and mild cognitive impairment: A randomized placebo-controlled trial.
    Lin PY; Cheng C; Satyanarayanan SK; Chiu LT; Chien YC; Chuu CP; Lan TH; Su KP
    Brain Behav Immun; 2022 Jan; 99():289-298. PubMed ID: 34755655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omega-3 fatty acids' supplementation in Alzheimer's disease: A systematic review.
    Canhada S; Castro K; Perry IS; Luft VC
    Nutr Neurosci; 2018 Oct; 21(8):529-538. PubMed ID: 28466678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
    Martins JG
    J Am Coll Nutr; 2009 Oct; 28(5):525-42. PubMed ID: 20439549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fish consumption and omega-3 fatty acid supplementation for prevention or treatment of cognitive decline, dementia or Alzheimer's disease in older adults - any news?
    Cederholm T
    Curr Opin Clin Nutr Metab Care; 2017 Mar; 20(2):104-109. PubMed ID: 27977429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fish,
    Saleh RNM; Minihane AM
    Proc Nutr Soc; 2022 Mar; 81(1):27-40. PubMed ID: 34632980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower omega-3 fatty acid intake and status are associated with poorer cognitive function in older age: A comparison of individuals with and without cognitive impairment and Alzheimer's disease.
    Phillips MA; Childs CE; Calder PC; Rogers PJ
    Nutr Neurosci; 2012 Nov; 15(6):271-7. PubMed ID: 22824373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Omega-3 Long Chain Polyunsaturated Fatty Acids (n-3 LCPUFA) Supplementation on Cognition in Children and Adolescents: A Systematic Literature Review with a Focus on n-3 LCPUFA Blood Values and Dose of DHA and EPA.
    van der Wurff ISM; Meyer BJ; de Groot RHM
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33053843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EFFECT OF EICOSAPENTAENOIC ACID AND DOCOSAHEXAENOIC ACID SUPPLEMENTATIONS TO CONTROL COGNITIVE DECLINE IN DEMENTIA AND ALZHEIMER'S DISEASE: A SYSTEMATIC REVIEW.
    de Souza Fernandes DP; Canaan Rezende FA; Pereira Rocha G; De Santis Filgueiras M; Silva Moreira PR; Gonçalves Alfenas Rde C
    Nutr Hosp; 2015 Aug; 32(2):528-33. PubMed ID: 26268080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 polyunsaturated fatty acid blood biomarkers increase linearly in men and women after tightly controlled intakes of 0.25, 0.5, and 1 g/d of EPA + DHA.
    Patterson AC; Chalil A; Aristizabal Henao JJ; Streit IT; Stark KD
    Nutr Res; 2015 Dec; 35(12):1040-51. PubMed ID: 26500082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and acceptability of anti-inflammatory eicosapentaenoic acid for cognitive function in Alzheimer's dementia: A network meta-analysis of randomized, placebo-controlled trials with omega-3 fatty acids and FDA-approved pharmacotherapy.
    Tseng PT; Zeng BS; Suen MW; Wu YC; Correll CU; Zeng BY; Kuo JS; Chen YW; Chen TY; Tu YK; Lin PY; Carvalho AF; Stubbs B; Li DJ; Liang CS; Hsu CW; Sun CK; Cheng YS; Yeh PY; Wu MK; Shiue YL; Su KP
    Brain Behav Immun; 2023 Jul; 111():352-364. PubMed ID: 37150266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.